Microarray Core B
微阵列核心B
基本信息
- 批准号:7846854
- 负责人:
- 金额:$ 8.61万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2002
- 资助国家:美国
- 起止时间:2002-06-01 至
- 项目状态:未结题
- 来源:
- 关键词:Academic Medical CentersBioinformaticsCancer CenterCandidate Disease GeneCollectionComplementary DNACore FacilityDNADNA analysisDataData QualityData SetDiabetes MellitusDiagnosisDigestive System DisordersDiseaseEnsureEquipmentExperimental DesignsGene ExpressionGene Expression ProfilingGene TargetingGenesGenetic PolymorphismGenomeGenome MappingsGenomicsGenotypeGoalsHumanIndividualInformaticsInvestigationInvestmentsKnowledgeLaboratoriesManuscriptsMapsMessenger RNAMethodologyMicroRNAsMicroarray Shared ResourceMolecularMolecular ProfilingMusOligonucleotide MicroarraysProcessPublishingRNA InterferenceResearchResearch PersonnelResearch TrainingResourcesReverse Transcriptase Polymerase Chain ReactionSamplingServicesSpottingsSupport SystemTechniquesTechnologyTimeTranslatingVariantbasecostdensitydesignexpression vectorfollow-upfunctional genomicsgene functionimprovedinterestmammalian genomemeetingspreventprogramsresearch studystructural genomicstoolweb interface
项目摘要
The large-scale analysis of gene expression profiles was the first hallmark in the transition from structural
genomics to functional genomics. Genomic-scale expression profiling experiments require large technical
and computational investments to facilitate both experimentation and the analysis of the large data sets
produced. These investments are beyond the capabilities of most laboratories or small groups. To provide
access to these important technologies, the DMA Microarray Core, operating within the Vanderbilt Microarray
Shared Resource (VMSR) has been established with major support from the VDDRC, the Diabetes
Research and Training Center, the Vanderbilt-lngram Cancer Center (VICC), and the Vanderbilt University
Medical Center Office of Research. The objectives of this core are to assist investigators in performing
genomic investigations using high-throughput and cutting-edge technologies that are financially or technically
prohibitive to utilize in individual labs. The services in the core have been substantially increased since the
last application. While previous services were limited to cDNA-based arrays produced in the core for mouse
and human, current services include a variety of commercial array platforms in addition to comprehensive
oligonucleotide arrays for mouse and human. Supported commercial arrays include Affymetrix, Applied
Biosystems, and CodeLink. In addition to gene expression profiling services, the core offers high-throughput
genotyping services using the Affymetrix mapping arrays and Targeted Genotyping (ParAllele) platforms.
Verification of microarray results (expression and genotyping) by real-time PCR is also available. The
newest services established in the core are profiling of microRNAs and the manipulation of gene expression
via RNAi and cDNA over-expression to support functional screens. The core continues to maintain a
comprehensive informatics program with two full-time analysts available. Significantly, the core has
developed an on-line project management system that supports all sample submission, project annotation,
and data access through an efficient web interface. Since 2002, the core has published several
manuscripts, processed hundreds of samples for VDDRC investigators, and continued to expand and refine
services to meet the research needs of the Vanderbilt DDRC.
The Core provides investigators with cutting edge access to human genomic technologies in order to
prevent, diagnose or improve treatment of digestive diseases and disorders.
基因表达谱的大规模分析是从结构分析转变的第一个标志。
基因组学到功能基因组学。基因组规模的表达谱实验需要大量的技术
和计算投资以促进大数据集的实验和分析
产生的。这些投资超出了大多数实验室或小团体的能力。提供
访问这些重要技术,即在范德比尔特微阵列内运行的 DMA 微阵列核心
共享资源 (VMSR) 的建立得到了 VDDRC、糖尿病协会的大力支持
研究和培训中心、范德比尔特-英格拉姆癌症中心 (VICC) 和范德比尔特大学
医学中心研究办公室。该核心的目标是协助调查人员执行
使用高通量和尖端技术进行基因组研究,这些技术在经济或技术上
禁止在个别实验室中使用。自成立以来,核心服务已大幅增加
最后一次申请。虽然之前的服务仅限于在小鼠核心中生产的基于 cDNA 的阵列
和人力,目前的服务除了全面的服务外,还包括各种商业阵列平台
用于小鼠和人类的寡核苷酸阵列。支持的商业阵列包括 Affymetrix、Applied
生物系统和 CodeLink。除了基因表达谱服务外,该核心还提供高通量
使用 Affymetrix 作图芯片和靶向基因分型 (ParAllele) 平台的基因分型服务。
还可以通过实时 PCR 验证微阵列结果(表达和基因分型)。这
核心中建立的最新服务是 microRNA 分析和基因表达操作
通过 RNAi 和 cDNA 过表达来支持功能筛选。核心继续保持
综合信息学计划,配有两名全职分析师。值得注意的是,该核心具有
开发了在线项目管理系统,支持所有样品提交、项目注释、
以及通过高效的网络界面进行数据访问。自2002年以来,核心已发布了多个
手稿,为 VDDRC 调查人员处理了数百个样本,并不断扩展和完善
服务以满足范德比尔特 DDRC 的研究需求。
该核心为研究人员提供了最先进的人类基因组技术,以便
预防、诊断或改善消化系统疾病和紊乱的治疗。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Shawn Edward Levy其他文献
Shawn Edward Levy的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Shawn Edward Levy', 18)}}的其他基金
Characterizing pediatric genomes through an optimized sequencing approach
通过优化的测序方法表征儿科基因组
- 批准号:
10017693 - 财政年份:2016
- 资助金额:
$ 8.61万 - 项目类别:
Characterizing pediatric genomes through an optimized sequencing approach
通过优化的测序方法表征儿科基因组
- 批准号:
10260464 - 财政年份:2016
- 资助金额:
$ 8.61万 - 项目类别:
Characterizing pediatric genomes through an optimized sequencing approach
通过优化的测序方法表征儿科基因组
- 批准号:
9356558 - 财政年份:2016
- 资助金额:
$ 8.61万 - 项目类别:
Characterizing pediatric genomes through an optimized sequencing approach
通过优化的测序方法表征儿科基因组
- 批准号:
9252143 - 财政年份:2016
- 资助金额:
$ 8.61万 - 项目类别:
Characterizing pediatric genomes through an optimized sequencing approach
通过优化的测序方法表征儿科基因组
- 批准号:
9815793 - 财政年份:2016
- 资助金额:
$ 8.61万 - 项目类别:
Characterizing pediatric genomes through an optimized sequencing approach
通过优化的测序方法表征儿科基因组
- 批准号:
9565172 - 财政年份:2016
- 资助金额:
$ 8.61万 - 项目类别:
相似国自然基金
蛋白质降解决定因子的生物信息学筛选及其耐药突变的多组学分析研究
- 批准号:32300528
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于生物信息学的类风湿性关节炎患者衰弱预测模型的构建与验证
- 批准号:82301786
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于结构表征的蛋白质与长链非编码RNA相互作用预测的生物信息学方法研究
- 批准号:62373216
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
突变和修饰重塑蛋白质亚细胞定位的生物信息学研究
- 批准号:32370698
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
自身免疫性疾病精准诊疗中基于非编码RNA组学和生物信息学的新方法研究
- 批准号:82371855
- 批准年份:2023
- 资助金额:74 万元
- 项目类别:面上项目
相似海外基金
Investigating High-Risk Epigenetic Modifying Alterations on JAK2VF Dependency and Fibrotic Progression in Myeloproliferative Neoplasms (MPNs)
研究骨髓增生性肿瘤 (MPN) 中 JAK2VF 依赖性和纤维化进展的高风险表观遗传修饰改变
- 批准号:
10723901 - 财政年份:2023
- 资助金额:
$ 8.61万 - 项目类别:
Integrating imaging and biopsy-derived molecular markers for the pre-surgical detection of indolent and aggressive early stage lung adenocarcinoma
整合成像和活检衍生的分子标记物,用于惰性和侵袭性早期肺腺癌的术前检测
- 批准号:
10737330 - 财政年份:2023
- 资助金额:
$ 8.61万 - 项目类别:
Boston Area Diabetes and Endocrinology Research Center (BADERC)
波士顿地区糖尿病和内分泌研究中心 (BADERC)
- 批准号:
10586200 - 财政年份:2023
- 资助金额:
$ 8.61万 - 项目类别:
Isabl GxT: A clinically actionable whole genome and transcriptome precision medicine platform
Isabl GxT:临床上可操作的全基因组和转录组精准医学平台
- 批准号:
10697472 - 财政年份:2023
- 资助金额:
$ 8.61万 - 项目类别: